Live news related to BIOTALYS stock (BE0974386188): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on BIOTALYS mainly cover M&A activity, share price moves et earnings publications. The stock trades at €2,04 on Euronext Paris, up 3,83% at the last update. This page lists the articles published on BIOTALYS stock to track the share price, company announcements and any item likely to influence market perception.
The Belgian biocontrol group's share price climbs this Wednesday, driven by a major regulatory decision obtained on the American market. The approval …
The Belgian biocontrol group has obtained registration of its Evoca biofungicide with the California pesticide authority. This decision is part of the…
Biotalys published its first-half 2026 results on August 20, 2026, marked by a decline in normalized net loss and cash of €11.9 million at the end of …
Agricultural biotechnology company Biotalys announced on Wednesday that its biofungicide Evoca has entered the public consultation phase with the Cali…
Patrick Van Beneden is leaving the board of the Belgian biotech company Biotalys, effective Tuesday, June 30, 2026. Serving as a non-executive directo…
Biotalys announced on Wednesday the successful completion of a private placement with its existing shareholders, raising 12.05 million euros. The tran…
Biotalys has released its annual results for 2025, showing an increased net loss and a significant decrease in cash reserves. The Belgian company, spe…
Biotalys soars this Tuesday, April 28, 2026, on Euronext, driven by the announcement of the first approval of its biofungicide EVOCA in the United Sta…
Shares of the Belgian biotech company specializing in agricultural biocontrol soared this Monday, April 27, 2026, on Euronext, driven by a major annou…
Biotalys has announced via press release that its innovative biofungicide, EVOCA, has been registered in the state of Florida. This marks the first ap…
